Hong Liu

ORCID: 0000-0002-4079-6985
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Cancer-related gene regulation
  • Gastric Cancer Management and Outcomes
  • Cardiomyopathy and Myosin Studies
  • Cardiac electrophysiology and arrhythmias
  • Metastasis and carcinoma case studies
  • Mitochondrial Function and Pathology
  • Cardiovascular Effects of Exercise
  • Fuel Cells and Related Materials
  • Ferroptosis and cancer prognosis
  • Esophageal Cancer Research and Treatment
  • RNA modifications and cancer

Minneapolis Heart Institute Foundation
2023-2024

University of Minnesota
2023-2024

Air Force Medical University
2022-2023

BACKGROUND: Emerging evidence suggests that atrial myopathy may be the underlying pathophysiology explains adverse cardiovascular outcomes in heart failure (HF) and fibrillation. Lower left (LA) function (strain) is a key biomarker of myopathy, but murine LA strain has not been described, thus limiting translational investigation. Therefore, objective this study was to characterize by speckle-tracking echocardiography mouse models myopathy. METHODS: We used 3 wild-type male female C57Bl6/J...

10.1161/circimaging.123.015735 article EN Circulation Cardiovascular Imaging 2023-10-01

TPS485 Background: Perioperative therapy, especially whether preoperative neoadjuvant therapy (NAT) can improve R0 resection rate and prolong overall survival of patients with locally advanced gastric cancer, has been paid more attention. NAT is mainly defined as a chemotherapy or chemoradiotherapy, aiming at increasing radical by downstaging tumor eliminating micrometastases. Anlotinib an oral multi-targeted tyrosine kinase inhibitor targeting VEGFR1/2/3, FGFR1-4 PDGFRα/β, which effectively...

10.1200/jco.2023.41.4_suppl.tps485 article EN Journal of Clinical Oncology 2023-01-24

Abstract Background: Epigenetic reprogramming has been reported to play a critical role in the progression of thyroid cancer (TC). RNA methylation accounts for more than 60% all modifications, and N6-methyladenosine (m6A) is most common modification RNAs higher organisms. The purpose this study was explore related mode m6A regulators construction its evaluation on clinical prognosis therapeutic effect TC. Materials methods: levels 23 Cancer Genome Atlas (TCGA) were analyzed. Differentially...

10.21203/rs.3.rs-1621649/v1 preprint EN cc-by Research Square (Research Square) 2022-05-17
Coming Soon ...